KARACHI: The Pakistan Pharmaceutical Manufacturers’ Association (PPMA) has warned the federal government that any decision to discontinue the import of raw material of medicines from India will weaken the country’s ability to fight coronavirus. The PPMA representatives appealed the federal government that it should continue with the existing arrangements of import of drugs’ raw material. Any decision to disrupt the international supply chains associated with the Pakistani pharmaceutical industry will lessen the ability of the country’s medical practitioners to treat the cases of Covid-19, they added. “We are in a virtual state of war against Covid-19 whose cases have been on the rise in Pakistan as the pharmaceutical industry is the backbone of the national apparatus put in place to fight the menace of coronavirus,” he said. The import of pharmaceutical raw material from India is being done under a proper SRO no 429 approved both by ministries of Commerce and National Health Services, he said.

Source: Pakistan Today May 11, 2020 18:00 UTC